Spire Healthcare’s response to the Competition Commissions provisional remedies

We welcome today’s publication of the Summary Provisional Decision on Remedies (PDR) of the Competition Commission (CC) in its investigation into the private healthcare market. Although the full PDR has not yet been published, the Summary supports our view – stated repeatedly throughout the process - that Spire Healthcare is not anti-competitive.

We note the five specific remedies proposed today by the CC. The detail of the four remedies which will affect Spire - relating to consultant incentive schemes, the management of PPU operations by private operators, the collection and publication of information on private hospitals and consultants’ performance, and the provision by consultants of fee information to patients - will be set out in the full PDR, but in principle Spire has no issue with them and will work with the CC to make them as effective as possible. The fifth remedy – which requires the divestment of certain hospitals – does not relate to Spire.

While this is not the end of the process, it is nevertheless an important milestone. With the final report due by early April 2014, we now look forward to bringing to an end this extended period of uncertainty for our patients, our employees and our suppliers, which has lasted for two years since the inquiry began.  In particular, I’d like to thank our employees, who have remained focused on delivering high quality care throughout this time.

We continue to focus on our strategy of growth, both organically and through acquisitions. As a sign of our continuing commitment to the private healthcare sector, since the start of the CC investigation (ie since April 2012) we have invested over £100 million in the business; in new scanners, new theatres, new services and in increasing surgical complexity. We also believe there will be further opportunities for Spire to invest in and expand its business. If a hospital came up for sale we would consider it carefully as an integral part of our long term strategy. 

Rob Roger, Chief Executive of Spire Healthcare, said:  “We welcome the publication of the Competition Commission’s provisional remedies, which supports our view that Spire Healthcare is not anti-competitive and are pleased that none of the divestment remedies relate to Spire.”

He continued: “The outlook for private healthcare, and for Spire in particular, is encouraging, especially as the economy recovers and employment rises. We look forward to the future with confidence.”

Requesting a copy of your medical records

If you would like to obtain a copy of your medical records please write to the Medical Records Department at the Spire Healthcare Hospital where you were treated. Please state your full name, date of birth and address. If your address was different at the time of your treatment please advise us of this. Please also ensure your letter is signed using your usual signature as we will verify this against signatures in your patient record to confirm your identity.

For more information about obtaining a copy of medical records held at a Spire hospital, please contact the hospital concerned.

Find a treatment, test or scan available at:

or

Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.

or

Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...

The latest health news

Visit our Health News section for the latest in healthcare news and medical research from the UK and abroad.

© Spire Healthcare Group plc (2016)